Genetic toxicology is the study of the toxic effects of chemicals and radiations on the hereditary material, or the DNA, of cells. Genetic toxicology, therefore, involves the study of chemically induced or radiation-induced DNA single-strand breaks and double-strand breaks, damage to DNA bases, mutations in DNA, and recombinational events in DNA mediated by exogenous agents (chemicals and ultraviolet [UV] and ionizing radiations) in bacteria, yeast, cells of the fruit fly, plant cells, and mammalian cells. Genetic toxicology also encompasses micronucleus formation, chromosomal aberrations, chromosomal aneuploidy, and morphological and neoplastic transformation of mammalian cells. In addition, genetic toxicology also includes chemical carcinogenesis in lower animals and in humans, because this often involves mutations in protooncogenes, activating them to oncogenes, and deleterious mutations in tumor suppressor genes, inactivating them. The importance of genetic toxicology is that it allows investigators to measure the DNA-damaging, mutagenic, and carcinogenic effects of chemical carcinogens and UV and ionizing radiations and it also allows investigators to study genetic damage and mutations in lower animals and humans.
DNA Damage
Many chemicals, and UV and ionizing radiations, can cause damage to DNA bases. This can result in a labilization of the DNA base-sugar phosphate bond. Bases can then depurinate or dissociate from the sugar phosphate backbone of DNA. This can leave that DNA strand which is lacking a DNA base, susceptible to attack by endonucleases, leading to cleavage of that strand by endonucleases. This will result in a break in a single strand of DNA. Single-strand breaks in DNA are easily recognized by centrifugation in alkaline sucrose gradients. The alkali separates the DNA strands, allowing a differential sedimentation of the longer from the shorter pieces of DNA. This separates the DNA strands and also allows visualization of the separated and broken strands. Using gel electrophoresis and specific plasmids treated with chemical mutagens or radiations also allows investigators to detect single-strand breaks in DNA. If these DNA single-strand breaks are not repaired correctly by DNA repair enzymes, this can lead to a cytotoxic event.
Similarly, a number of chemical agents and ionizing radiations can lead to one or more breaks in both strands of DNA simultaneously. This is called a DNA double-strand break.
Ionizing radiations, such as X-rays and neutrons, are very effective in depositing a sufficient amount of energy into DNA to result in DNA double-strand breaks. DNA double-strand breaks are easily recognized by centrifugation in neutral sucrose. These types of breaks of the DNA strands are difficult to repair by the DNA repair machinery of the cell. If they are not repaired correctly, these DNA double-strand breaks can lead to cytotoxicity.
UV light (254 nm) and certain chemical mutagens can also efficiently induce cross-links in DNA. These can be manifested as either intrastrand DNA cross-links, that is, occurring within one strand of DNA, or interstrand DNA cross-links, which occur between two strands of DNA. These types of DNA cross-links can inhibit DNA replication and transcription. This can cause the cell to remain in a static state, where it is trapped and cannot proceed through mitosis. In such a state, a cell can become degraded by nucleases and proteases, leading to cell death. Hence, it is very important for the cell to repair these types of DNA cross-links, so the cell can complete DNA synthesis and mitosis, commence transcription, and survive. Examples of agents that are efficient at inducing DNA cross-links are UV light of 254 nm, nitrogen mustard, and psoralen plus UV light.
In addition, ionizing radiations (X-rays and gamma rays) and certain chemicals (such as bleomycin and adriamycin) or ionizing radiations that generate active oxygen species, such as superoxide, can cause oxidative damage to DNA bases. Bleomycin and adriamycin are examples of chemicals that can generate superoxide. Superoxide can then dismutate in the presence of the enzyme, superoxide dismutase, which can lead to the generation of hydrogen peroxide. The reaction of hydrogen peroxide and additional superoxide in the presence of ferrous iron can then lead to generation of hydroxyl radicals. Hydrogen peroxide and hydroxyl radicals can oxidize DNA bases, and this can then generate mutations and cytotoxicity.
A fifth type of DNA damage results from the covalent binding of chemical mutagens and mutagenic chemical carcinogens to DNA bases. An example of this is the chemical mutagen and mutagenic chemical carcinogen, N-methyl-N 0 -nitro-Nnitrosoguanidine (MNNG). MNNG is thought to generate methyl carbonium ions, which can bind covalently to the O-6 position of guanine, and to the N-7 position of guanine in DNA, leading to mutations, cytotoxicity, and carcinogenesis. The chemical carcinogen, benzo(a)pyrene (BaP), is metabolized to diol epoxide metabolites. One of the metabolites, the antibenzo(a)pyrene 7,8-dihydroxydiol-9,10-epoxide, can bind covalently to the exocyclic amine of guanine in DNA, leading to a covalent adduct. Covalent mutagen/carcinogen-DNA base adducts are very stable and can lead to cytotoxicity, mutation, or carcinogenesis if they are not repaired properly.
DNA Repair

DNA Repair in Bacteria
It was now known that in bacteria, yeast, and mammalian cells, there are enzymatic systems that can repair damaged DNA. These systems are known as DNA repair systems. Much of the DNA repair that takes place in bacteria and in mammalian cells whose DNA has been damaged by chemical mutagens or by ionizing radiations, proceeds with a high degree of fidelity, and repairs the DNA damage correctly. However, a certain small fraction of this DNA repair proceeds incorrectly, and this misrepair leads to mutations. While some of this misrepair generates mutations and can be cytotoxic, a fraction of this misrepair is beneficial by generating mutations that can lead to genetic diversity in organisms and hence provides new organisms that can lead to evolution of various species.
In bacteria, a number of DNA repair systems are now recognized. The first repair system, which has been the most intensively studied and the best understood, is the system of photoreactivation repair or direct repair. This repair system is very efficient at repairing thymine dimers containing a cyclobutane ring formed between thymine bases in DNA by absorption of UV light of 254 nm by the thymine bases. In photoreactivation repair, an antenna pigment, methylene tetrahydrofolate (MTHF), absorbs near UV light of wavelength 350 nm. MTHF then transfers the energy of this photon by Forster resonance energy transfer to reduced flavin adenine dinucleotide (FADH). FADH then transfers an electron to the thymine dimer, which decomposes it, returning it to its original state of two separate thymine bases in DNA. This repair takes place in the presence of the photoreactivating enzyme, which contains a pocket that binds to and holds the thymine dimer in place. Since this repair system returns the thymine dimer to its original separate thymine bases in DNA, no mutations occur during this process. Hence, this repair is said to be 'error free,' and it does not induce mutations. The gene that encodes the photoreactivating enzyme has been cloned and sequenced, and the photoreactivating protein has been purified and sequenced. X-ray crystallographic analysis of the photoreactivating enzyme has revealed the structure of this enzyme. It contains two globular domains, an NH 2 domain and a COOH domain, connected by a bridge consisting of 71 amino acids. The MTHF antenna pigment and the FADH cofactor fit above and below the amino bridge connecting the two globular domains. The cyclobutane pyrimidine dimer flips out from the DNA and binds to a 'pocket' in the photoreactivating enzyme. This structure easily allows the MTHF to absorb light of 340 nm, to pass the energy of this light to the FADH cofactor by Forster resonance energy transfer, and for the resultant FADH* to pass an energetic electron to the cyclobutane pyrimidine dimer, causing this structure to rearrange back into two separate thymine bases, which is the original structure before thymine dimer formation.
A second DNA repair system in bacteria is designated excision repair. This repair system efficiently repairs DNA strands that have been irradiated with UV light or ionizing radiations, oxidatively damaged, or that have chemical-DNA base covalent adducts in them. This system involves the steps of incision by an incision endonuclease proximate to the site of the damage, followed by excision of the damaged DNA bases by DNA polymerase I. Next, DNA polymerase I (the Arthur Kornberg enzyme) fills in the resulting nucleotide gaps by adding nucleotides complementary to the undamaged strand, using the undamaged strand as a template, and synthesizing DNA in a 5 0 to 3 0 direction. Finally, DNA ligase seals the phosphodiester chain. This repair proceeds with a high degree of fidelity, and, therefore, only induces a very low frequency of mutations. Some authors refer to this as 'error-free' DNA repair, although a low frequency of mutations is created by this repair system. As noted before, a low frequency of mutations is beneficial to evolution and is therefore acceptable.
A third type of DNA repair is called the SOS response. The SOS response involves the induction of two different types of DNA repair. In this situation, where there are thymine dimers in DNA due to UV irradiation of the DNA or other DNA damage, a normally quiescent molecule, called the rec A protease, binds to the site of this DNA damage. The binding of rec A to damaged DNA causes the rec A protease to become catalytically active, and this active rec A was designated as rec A*. The rec A* protease then binds to Lex A repressor molecules that are already bound to various genes of the bacterial genome. Lex A repressor molecules normally bind to the SOS boxes of genes in the genome that encode endonucleases, exonucleases, helicases, DNA polymerases, and other molecules important in SOS repair and in postreplication recombination DNA repair. When the activated rec A protease binds to the Lex A repressors, this causes the Lex A repressors to autocatalytically cleave themselves. This results in the induction of the synthesis of w50 protein molecules involved in DNA repair, among them an error-prone DNA polymerase. This error-prone DNA polymerase is composed of two umuD 0 molecules and one umuC molecule, with the formula, umuD2 0 C. This error-prone DNA polymerase causes nucleotide synthesis to occur opposite the thymine dimers, with a low degree of fidelity. This leads to high frequencies of mutations in the DNA, on the order of 1/1000 nucleotides. This, however, is acceptable, because otherwise, failure to repair UV-damaged DNA at the replication fork before the cell divides can kill the cell. In addition, during the SOS response, postreplication, recombination repair is simultaneously induced. In postreplication, recombination repair, the rec A* protease also acts as a recombinogenic enzyme. In this case, at a replication fork containing a thymine dimer, rec A-mediated recombination can occur to generate a situation in which there is at least one good template for DNA synthesis on each strand of the replication fork. While allowing DNA repair and hence DNA synthesis to proceed, rec A-mediated recombination is also a process that proceeds with a low degree of fidelity, with error rates of 1/1000, leading also to mutations.
DNA Repair in Mammalian Cells
DNA repair systems similar to those in bacteria also exist in mammalian cells.
The first type of DNA repair in mammalian cells is base excision repair. A situation arising in which this type of DNA repair is utilized occurs when a DNA base is chemically damaged. In this situation, a DNA glycosylase removes the damaged DNA base from the DNA. This results in an apurine site or in an apyrimidinic site. The next step is that DNA polymerase fills in the apurinic site or the apyrimidinic site with the correct base. DNA polymerase b fills in short patches in the DNA. DNA polymerase 3 fills in longer patches of DNA. Then, the next step is that DNA ligase connects the DNA parental strands.
The second type of DNA repair in mammalian cells is nucleotide excision repair (NER). In NER, the cell can remove bulky lesions from DNA. The NER repair system utilizes 30 proteins to remove damaged bases from DNA. The five steps in NER are recognition of DNA damage, incision, excision, DNA repair synthesis by DNA polymerase g or 3, and ligation by DNA ligase I. In this repair, the damaged DNA base blocks transcription, and stalled RNA polymerase provides a signal to initiate repair of the transcribed DNA strand.
A third type of DNA repair in mammalian cells is DNA double-strand break repair. There are two types of double-strand repair: homologous recombination and nonhomologous recombination. In homologous recombination, either exonucleases or helicase produce a 3 0 -ended, single-stranded tail, and this tail then invades an undamaged homologous DNA, and with DNA synthesis, a 'Holliday junction DNA complex' is formed. This junction is then cleaved to produce two undamaged DNA molecules. A second type of double-strand break repair is called nonhomologous end joining (NHEJ). In NHEJ, a DNA-dependent protein kinase (DNA-PK) aligns broken DNA ends, which facilitates their ligation, which is performed by DNA ligase IV. DNA-PK also is believed to act as a signal molecule to help recruit other proteins involved in NHEJ.
A fourth type of DNA repair in mammalian cells is mismatch repair. This type of repair fixes mismatched bases formed during DNA replication, genetic recombination, and DNA damage caused by chemical agents and radiations. The steps in mismatch repair include damage recognition by proteins that bind to the site of the damage, stabilizing the binding by adding more proteins, cutting the DNA at a distance from the mismatch, excision past the mismatch, resynthesis of DNA, and ligation.
There is also a fifth type of DNA repair called O-6-methylguanine-DNA methyltransferase repair. In this type of repair, a methyl group is transferred from an O-6-methylguanine in DNA to O-6-methylguanine-DNA methyltransferase.
Mutagenesis
Overview of Mutagenesis and Its Biological Significance
What is mutagenesis and why it should be concerned with this process? Mutations are changes in the hereditary material of cells, their DNA, that cause observable changes in hereditary traits in offspring. These changes are transmitted to the RNA, which is synthesized according to the instructions carried by the DNA, and then to proteins, which conduct chemical (enzymatic) reactions in the cell or serve as structural materials, giving a cell its shape. Mutagenesis is the process by which mutations are induced in the cells of organisms.
Mutations can have beneficial effects, deleterious effects, or no consequences in organisms. Certain mutations have a positive effect on the organism. The sickle cell mutation in the hemoglobin gene and hence the hemoglobin protein molecule, for instance, is thought to give humans in Africa an ability to survive malaria better. The resulting mutated hemoglobin aggregates in the red blood cells, leading them to assume a sickled shape, which makes it difficult for the malarial parasite to enter and infect the red blood cells. Many mutations are neutral and have no significant effect on the organism at all. However, certain types of mutations can have deleterious consequences in organisms. An example of a deleterious mutation in humans is one that destroys the activity of an enzyme called adenosine deaminase, leading to a deficient immune system and a consequent inability to fight disease, as occurred in the famous 'bubble boy.' Other deleterious mutations, such as mutations in the germ cells (sperm or egg cells), can lead to a predisposition to cancer, such as the Li-Fraumeni syndrome, or the condition predisposing persons with a mutation in one of the retinoblastoma (Rb) genes to incur a tumor of the eye called retinoblastoma at high frequencies. Still other mutations can be lethal and result in nonviable offspring. Mutation is an inevitable process, and it is occurring all the time spontaneously. Mutations that lead to beneficial traits in an organism will be selected for, and mutations that lead to defects in critical cellular properties or to the death of the organism will be selected against, during the course of evolution.
During the past 100 years, a significant amount about the nature and effects of mutations on cell growth and survival and on the growth and survival of various organisms was learned. Mutations have been most intensively studied in bacteria because bacteria grow very rapidly, and the mutations are rapidly expressed. From experimental studies, it is now known that UV and ionizing radiations and specific chemicals called mutagens can induce mutations in bacteria, in yeast, in plants, in the fruit fly Drosophila, in single mouse cells in culture, in mice, in single human cells in culture, and in humans, although the last has been less well studied. A significant amount concerning mutations in the fruit fly, Drosophila melanogaster, and a significant amount concerning the effects of mutations in mice are known. Using recently developed assays to detect mutations in humans by analyzing the white blood cells of humans, a knowledge concerning the induction of mutations in humans caused by ionizing radiations (e.g., the atomic bomb survivors in Hiroshima and Nagasaki), mutations caused by mutagenic cancer chemotherapeutic agents, and mutations caused by cigarette smoke was acquired. With current methods using techniques of molecular biology, the presence of certain mutations believed to be deleterious in humans was detected, and genetic counseling can occasionally help certain families.
Scientists have also learned a substantial amount regarding cancer induction by mutagenic chemical carcinogens and mutagenic UV and ionizing radiations. A very important finding in this field is that UV and ionizing radiations and specific chemical mutagens induce mutations in specific cellular genes called proto-oncogenes, which activate them to oncogenes. Chemical mutagens and ionizing radiations can also cause amplification of these proto-oncogenes, leading to higher steady state levels of the protein products of proto-oncogenes. These agents can also cause chromosomal breakage and translocation of a part of the chromosome(s) bearing proto-oncogenes to other chromosomes, where the proto-oncogenes can be placed under the control of different promoters of gene expression or fused with other genes, leading to aberrant proto-oncogene products. Mutagens also induce deleterious or inactivating mutations in other genes called tumor suppressor genes, inactivating them, or cause partial or full deletions of these genes, leading to loss of the tumor suppressor gene protein products. Combinations of activating mutations in proto-oncogenes and inactivating mutations in tumor suppressor genes, on the order of 15 or more such mutations, in somatic (non-germ line) or germ line cells play a key role in carcinogenesis, or the process of cancer induction caused by mutagenic chemical carcinogens, in humans. Specific details of the types of mutations that occur in organisms and their biological significance are as follows.
Definition and Description of Mutations
As has been well known since the pioneering experiments of Griffith, Avery, MacLeod, McCarty, Watson, and Crick, DNA is the genetic material of bacterial and mammalian cells. DNA encodes information in a triplet code which specifies the sequence of amino acids in proteins. Proteins are the enzymatic and structural polymers of cells. DNA consists of two antiparallel chains of nucleotides. Hydrogen bonds between bases on one strand and bases on the opposite strand constitute in the aggregate sufficient bond strength to keep the double helix of DNA intact. However, even at room temperature, sufficient energy is deposited in the DNA helix that the hydrogen bonds constantly break and reform, leading the DNA base pairs to occasionally separate, and the DNA structure to 'breathe.' DNA is replicated in a semiconservative fashion, as shown by the original experiment of Drs. Meselson and Stahl, such that each original strand serves as a template on which a new complementary strand is replicated. In this replication, complementary DNA bases are added to bases on the original strand, such that guanine pairs with cytosine and thymine pairs with adenine, as accomplished by DNA polymerases. In bacteria, DNA polymerase III accomplishes a large fraction of DNA synthesis, aided by DNA polymerase I, which works on the lagging strand.
The sequence of DNA is specified very precisely. A mutation is any change in the sequence of DNA bases from the original sequence of DNA bases. In the simplest form, during replication, the DNA polymerase enzymes can accidentally substitute an adenine for a guanine opposite a cytosine during DNA replication. This simple kind of mutation would be called a transition mutation, in which one purine, guanine, was instead replaced by another purine, an adenine base. Similarly, if during replication a pyrimidine base, such as thymine, was supposed to be inserted opposite an adenine base on the template strand, but instead a cytosine was inserted opposite the adenine, this would also be called a transition mutation. A transversion mutation is one in which a purine base substitutes for a pyrimidine base (guanine for thymidine) or a pyrimidine base substitutes for a purine base (cytosine for adenine). These types of mutations are also more generically called base substitution mutations.
The next more complex type of mutation is referred to as an addition or deletion mutation. In a deletion mutation, one or more bases are removed from the DNA. In an addition mutation, one or more bases are added to the DNA. Addition mutations are also called insertion mutations. Deletion mutations are called small deletions if only a few bases are deleted from the DNA or large deletions if many bases are deleted from the DNA. The same considerations hold for small addition and large addition mutations.
So far, mutations in which the genetic code is kept in strict register were only considered. As is commonly known, the genetic code is read in triplets, such that three nucleotides are read together to specify one specific amino acid. With base substitution mutations, only one base is changed, so the amino acid specified by the new triplet nucleotide specifies a new amino acid. However, the rest of the nucleotide sequence remains the same, so the protein specified only has one amino acid changed in it. This situation is similar in the case of addition and deletion mutations, provided the addition or deletion is three bases or a multiple of three bases. Of course, in this situation, there is gain or loss of one or more amino acids, and this can have severe consequences for the resultant protein, depending on where in the protein the amino acids are inserted or deleted. However, beyond the site at which the three base addition or deletion is induced, the genetic code remains in register, and the rest of the protein, beyond the addition or deletion mutation of three or a multiple of three nucleotides, will remain normal.
A special circumstance arises when one or two bases, or any multiple of one or two bases, but not three bases, are deleted or inserted into a DNA sequence. In this case, the sequence of bases encoding amino acids is now shifted out of register. The original amino acids in the encoded protein are changed, and the code is shifted out of register at and beyond the site of this type of mutation. Hence, a new or 'scrambled' protein is produced from the site of the mutation onward. Such a special type of mutation is called a frameshift mutation, since the coding frame is shifted out of its original alignment. In this case, the structure of the protein is 'scrambled' from the site of the deletion or insertion on through the rest of the protein. In this case, the protein can have an altered structure, and if the protein is an enzyme, the enzymatic activity of the protein may be decreased or abolished.
Another simple type of mutation that needs to be considered is gene amplification. In this case, a gene is copied into many more replicas of that same gene. The extra copies of this gene are then inserted into the DNA. A further type of mutation is due to a translocation of a gene sequence. In mammalian cells, there is the additional complication that the DNA and its genes are arranged on discrete chromosomes. These chromosomes can be broken, and pieces from one chromosome attached to another chromosome, to form a structure known as a translocation. This can result in a deletion mutation if the sequences are not joined correctly and can also result in the translocated gene being placed next to a strong promoter element, which can cause the gene to be read more frequently, affecting expression of this gene.
Consequences of Specific Types of Mutations
The consequences of transition mutations and transversion mutations depend on where they occur in a gene coding for a protein. If they occur in a site that does not significantly change the shape of a protein used to maintain the structural integrity of a cell, or in a site that does not affect the structure of an enzyme or its active site, then they do not have a significant effect on the structure of the cell or on the enzymatic activity of a protein. If, however, the transition or transversion mutation occurs in a part of the protein that significantly changes its structure or alters the structure of its active site, decreasing its enzymatic activity, then the mutation can have severe negative consequences for the survival of the cell.
Three base additions and deletions similarly may not have severe consequences if they occur in a region of the protein that does not affect the structure of the protein or does not affect the active site of the enzyme, and hence does not affect its enzymatic activity. Of course, if these deletions and additions occur in critical parts of the protein that affect its structure, or in the active site of an enzyme, they can have significant effects on cell survival and the phenotype of the cell.
The frameshift type of mutation is one in which one, two, or a multiple of two bases are added or deleted. This is called a 'frameshift mutation' because the genetic code of this gene product is shifted out of register, and hence the resulting protein is 'scrambled' from the site of the frameshift mutation toward the end of the protein. Frameshift mutations are usually deleterious to protein structure and enzymatic activity. Such mutations 'scramble' the structure of the protein downstream from the mutation and hence destroy the structural integrity of structural proteins and destroy the enzymatic activity of enzymes.
General Types of Mutagens: The Concept of Metabolic Activation
Broadly speaking, there are six general types of mutagens. First, there are mutagens that are 'fraudulent' DNA bases. These are bases whose structures are similar to but somewhat different in structure than the normal bases. An example of such a base is 5-bromouracil, which is similar in structure to the normal base thymidine and can substitute for thymidine in DNA, but which has different hydrogen bonding properties and hence different base-pairing properties than thymidine. Approximately 33 base analogs have been synthesized and their mutagenic properties studied.
Second, there is a group of mutagens called frameshift mutagens. These mutagens are, in general, large, planar aromatic molecules that can intercalate into the DNA. In the process of intercalation, the intercalators slip into the DNA and lie flat between two adjacent base pairs, with the plane of the intercalator lying flat upon the planar aromatic rings of the base pairs. New bonds are formed between the II electron clouds of the DNA bases and the II electron clouds of the intercalating aromatic molecules, which stabilize the new intercalated structure. Treatment of cells with this type of mutagen increases the frequency of occurrence of frameshift mutations. Examples of such mutagens include acridine orange, acriflavine, and ethidium bromide. These molecules are highly fluorescent and are commonly used to stain DNA in agarose gels, due to their intercalating and fluorescent properties.
The third group of mutagens are the direct alkylating agents. These mutagens generate methyl and ethyl carbonium ions, which are chemically reactive and readily bind covalently to nucleophilic groups on the bases of DNA, including but not limited to, the O-6 atom of guanine and the N-7 atom of guanine. Examples of these alkylating mutagens are MNNG, methyl methanesulfonate (MMS), ethyl methanesulfonate (EMS), and epoxides such as ethylene oxide. There are also alkylating agents that have two reactive groups on the same molecule, such as nitrogen mustard. Nitrogen mustard and similar molecules can bind to both strands of DNA, leading to a cross-link between them, or to two places within one strand of DNA, leading to an intrastrand cross-link. UV light can also cause formation of intrastrand and interstrand cross-links in DNA.
Fourth, there is a large group of mutagens referred to as premutagens or promutagens. These compounds are chemically inert and usually very hydrophobic. All organisms must metabolize these hydrophobic compounds to make them sufficiently water soluble for excretion from the cell membrane and from the organism. Otherwise, these hydrophobic molecules will bioaccumulate in the hydrophobic regions of membranes of cells, causing inhibition of the functioning of enzymes in membranes, inhibition of membrane transport functions, and damage to the integrity of the membrane, which delineates the cell from its environment. Examples of such hydrophobic molecules are the polycyclic aromatic hydrocarbons (PAHs), such as the ubiquitous environmental pollutant and carcinogen, benzo(a)pyrene (BaP). BaP is formed when organic matter is burned in a paucity of oxygen, because its aromaticity places it in a low-energy state. In order to remove these hydrophobic molecules from cells, organisms utilize cytochrome P450 enzymes plus atmospheric oxygen, plus reducing equivalents such as reduced nicotinamide adenine dinucleotide phosphate (NADPH) and reduced nicotinamide adenine dinucleotide (NADH), to epoxidate the hydrophobic molecules, in the case of PAHs, activating them to epoxides, which are mutagens. The epoxides can be attacked by water and epoxide hydrolase to form dihydrodiols. A second attack of the cytochrome P450 enzyme upon the dihydrodiols can lead to dihydrodiol epoxides. These two steps result in the generation of an active mutagen, in the form of a dihydrodiol epoxide. This active mutagen can react with DNA bases to cause formation of DNA base-BaP dihydrodiol epoxide adducts, which can be repaired incorrectly, leading to mutations in the cells, although many of these reactive molecules will subsequently react with water via the enzyme epoxide hydrase or with glucose, sulfate, or glutathione via enzymatic processes to form water-soluble conjugates that can be excreted in the urine. Examples of such promutagens or premutagens are the PAHs (e.g., benzo[a]pyrene) and the aromatic amines (e.g., b-naphthylamine). An additional unique and powerful promutagen is an epoxide metabolite of the fungus, Aspergillus flavus, called aflatoxin B1. Aflatoxin B1 serves as a biocide against other microorganisms to preserve the ecological niche of A. flavus. Other examples of promutagens include the large group of nitrosamines. Dimethyl-nitrosamine, or DMN, is one example of a potent mutagenic, carcinogenic nitrosamine.
Fifth, it must be pointed out that the PAHs can intercalate into DNA and also are metabolized to active alkylating agents such as epoxides. Hence, PAH and similar promutagens form a fifth set of complex mutagens that can intercalate into and alkylate DNA bases, therefore inducing base substitution and frameshift mutations. Other compounds that bind specifically to DNA in a physical sense, such as aflatoxin, and are metabolically activated to epoxides that bind covalently to DNA bases, are also included in this group of complex mutagens, which can both bind to DNA and generate alkylating moieties upon metabolism by cytochrome P450 enzymes.
A sixth group of bacterial mutagens that are active at the DNA level are metal salts. These include compounds of the elements nickel, chromium, and arsenic (a metalloid). Some metal salts are carcinogenic when inhaled by lower animals, cause chromosomal damage in cultured murine and human cells, and are carcinogenic to occupationally exposed humans. Soluble hexavalent chromium compounds are mutagenic and clastogenic. Particular insoluble chromium compounds containing hexavalent chromium induce lung tumors when inhaled by lower animals. Specific insoluble chromium compounds can also be inhaled by humans in the chrome plating or chromium-manufacturing industries and can induce lung cancer. Specific insoluble nickel compounds, such as nickel subsulfide and black and green nickel oxides, are carcinogenic in animals. In nickel refinery operations in the past, humans have inhaled aerosols of mixtures of soluble and insoluble nickel compounds and have also smoked cigarettes and have shown increased incidences of nasal and lung cancer. Specific insoluble nickel compounds are phagocytosed into cultured murine and human cells and cause oxygen radical generation, chromosomal breakage, and enhancement of DNA methylation in these cells. Arsenic compounds are also carcinogenic in humans. This occurs when copper ores containing arsenic are smelted. Roasting copper ores leads to generation of arsenic trioxide, which induces lung cancer in humans. Drinking water contaminated with arsenic compounds also leads to lung cancer and bladder cancer in humans in Taiwan, where the artesian wells are contaminated with arsenic compounds. Arsenic compounds induce lung cancer, urinary bladder cancer, skin cancer, liver cancer, and leukemias. Methylated metabolites of inorganic arsenic compounds, including mono-metyl arsenous acid (MMA) and dimethyl arsenous acid (DMA) are believed to generate oxygen radicals, which can induce DNA damage, leading to cancer in mammals.
Molecular Mechanisms of Mutagenesis
Mechanistically, the simplest type of mutagenesis occurs when the enzyme DNA polymerase III is copying one strand of DNA into its complementary strand and places the incorrect nucleotide into the newly synthesized strand of DNA. Although it is thermodynamically favored that the correct base will be inserted, there is a lesser but real probability that the incorrect base will be inserted during DNA replication. An example would be placement of the wrong base, adenine (A), opposite the DNA base cytosine (C), instead of inserting the correct base guanine (G) opposite the base C. This results in what is described as a G/C to A/T transition mutation, and it is called a spontaneous mutation.
A second type of induced mutagenesis occurs when an alkylating agent, such as MNNG, reacts with the base guanine in DNA and places a methyl group on the oxygen in position 6 of guanine to form an ether linkage. During the normal replication of the DNA, guanine pairs with cytosine, with which it makes three hydrogen bonds. When guanine is methylated on the oxygen in position 6, due to treatment with MNNG, this methylated guanine still frequently pairs with cytosine, but it now incorrectly pairs with an incoming thymine at an increased frequency, instead of the cytosine with which a normal guanine would pair. This results in a G/C to A/T transition mutation.
Deletion and addition mutations are caused when the DNA 'breathes' or opens its structure and occasionally a piece of this DNA loops out. This occurs because the energy of room temperature (kT, where k is the Boltzmann constant and T is the temperature) is sufficient to dissociate some of the hydrogen bonds which hold the two DNA strands together. When part of a DNA strand loops out, and when an intercalator molecule, such as acridine orange or ethidium bromide, subsequently intercalates into the DNA strand at a looped out structure, it can stabilize this looped out structure. Intercalation occurs when the intercalator molecule (acridine orange, acriflavine, or ethidium bromide) inserts into the DNA and binds to a set of DNA bases by aligning parallel to them. Intercalation is driven when the II electrons of the intercalator molecular bind to the II electrons of the DNA base. DNA repair enzymes can then recognize this looped out structure in DNA as an aberrant structure and can then excise this structure out of the DNA by use of incision endonucleases and DNA polymerase I. This process would then result in a deletion mutation. Addition mutations may be caused by insertion of extra DNA bases during DNA replication. This can happen spontaneously. It is also thought to happen when a DNA polymerase either slips along runs of GC base pairs or when the polymerase incorrectly recognizes the intercalator molecule as a DNA base.
As mentioned previously, the planar PAHs are very complex molecules. They can intercalate into DNA. In addition, by virtue of their being metabolized into epoxides, they can also simultaneously covalently bind to DNA bases. Hence, they can cause base substitution mutations (transitions and transversions) and can also cause frameshift mutations when they are copied by the DNA polymerase incorrectly and incorrect nucleotides are inserted into the DNA, leading to mutations in the DNA. PAH bound to DNA also cause a labilization of the DNA base-sugar bond, leading to depurination of the PAH-adducted base. During DNA repair, the DNA polymerase occasionally adds the correct base back at the depurinated site, but often adds an incorrect base, leading to frequent transversion mutations at the depurinated site.
Bacterial Mutagenesis Detection Systems
Two assays in bacteria are commonly used to detect and study the molecular mechanisms of mutation in bacteria and also to screen chemicals to determine whether they are mutagenic to bacteria. The most commonly employed assay is that of reversion of mutant Salmonella typhimurium bacteria back to wild-type or normal bacteria, developed by Professor Bruce Ames and colleagues at the Department of Biochemistry of the University of California at Berkeley in Berkeley, California. In this assay, suspect mutagens plus a source of metabolic activation in the form of S-9 are added to and incubated with S. typhimurium bacteria. S-9 is a preparation of rat liver, in which the rat liver has been homogenized, then centrifuged at 9000 g, and the supernatant is utilized, while the pellet is discarded. Rat liver S-9 contains cytochrome P450 and other xenobiotic metabolizing enzymes. The specific Ames 0 strains of S. typhimurium contain mutations in the genes encoding enzymes that biosynthesize histidine, inactivating them, such that these mutant bacterial strains cannot grow unless exogenous histidine is provided. In this assay, the investigator counts the number of mutated bacteria that can now grow in medium lacking histidine and scores these as reverted mutant bacteria. This assay is very effective at detecting the mutagenicity of chemicals. Since reversion is very specific, it is common for investigators to use two Ames 0 strains to detect base substitution mutations, two Ames 0 strains to detect frameshift mutagens, and one strain of bacteria to detect mutagens that generate oxygen radicals. This assay also identifies 50% of all chemical carcinogens that are mutagenic carcinogens by detecting their mutagenicity. This assay is commonly used by industrial firms such as pharmaceutical companies, by governmental agencies charged with regulating the containment of carcinogenic substances, and by researchers interested in identifying new chemical mutagens and in understanding the molecular mechanisms of chemical mutagenesis. It is a rapid assay that takes only 2 or 3 days to complete and is relatively inexpensive ($500 or less per assay in the commercial sector).
A second bacterial mutagenesis assay, formulated by Dr William Thilly and colleagues at the Massachusetts Institute of Technology, is based on the Ames' assay. In this assay, the Ames' Salmonella bacterial strains are used, but the assay is a forward mutation assay, in which bacteria are treated with chemical mutagens plus or minus S-9 metabolic activation. Then, the number of bacterial colonies resistant to the toxicity of 8-azaguanine are scored as mutant colonies. This assay has been claimed to be more sensitive than the original Ames' assay because the entire genes should be the targets for mutagenesis, as opposed to small parts of histidine-synthesizing genes (usually single nucleotides) in the Ames 0 reversion assay. However, the forward mutation assay of Thilly and colleagues is employed far less frequently than the Ames 0 assay. A large body of work has been done to characterize and understand the molecular bases by which the Ames 0 assay functions, and a very large number of mutagens have been detected and studied in the Ames' assays. Hence, today, the Ames' assay remains the assay of choice to detect bacterial mutagens.
In both bacterial mutagenesis assays, one plots the number of mutant colonies on the ordinate (y-axis) versus the concentration of test compound on the abscissa (x-axis). The plots are usually linear up to the point at which cytotoxicity overwhelms mutation induction, and the number of mutants passes through a maximum and then declines. Hence, bacterial mutagenesis studies are usually conducted with low concentrations of chemical compounds or radiations that induce a linear frequency of mutations but do not cause significant cytotoxicity.
Mammalian Cell Mutagenesis Assays
In mammalian cells, it is common to utilize mutagenesis assays that measure induction of mutants that are resistant to the cytotoxicity of toxic drugs. One of the most frequently employed mutation assays in mammalian cells is the assay detecting mutation conferring 6-thioguanine resistance. This assay is most frequently employed in the Chinese hamster ovary (CHO) cell line or in the V79 Chinese hamster lung fibroblast cell line. In this assay, the original or 'wild-type' cells are killed by the cytotoxic drug 6-thioguanine or its closely related analog, 8-azaguanine. These drugs enter mammalian cells and react with the cellular metabolite, 5 0 -phosphoribosyl-pyrophosphate (PRPP), to form a toxic nucleotide which is incorporated into DNA and RNA, leading to cell death. In the assays to detect mutation, the cells are treated with the suspect mutagen plus and minus S-9 (cytochrome P450) metabolic activation. Next, the treated cells are reseeded into new cell culture medium containing 6-thioguanine or 8-azaguanine, which is called a mutant-selective agent. 6-Thioguanine or 8-azaguanine (they have similar effects) kills all the wild-type cells at sufficiently high concentrations and therefore selects against the wild-type cells. However, both spontaneous and mutageninduced mutant cells are resistant to the cytotoxicity of 6-thioguanine and continue to grow and form discrete colonies. Once the mutant colonies have reached sufficient size to be visible by eye and under the microscope, the medium is removed from the dishes, the colonies are rinsed with phosphate-buffered saline, and then these mutant colonies are then fixed to the dishes with methanol or 70% ethanol, stained with the nuclear stain, Giemsa, or crystal violet, and then scored following examination under a dissecting microscope. The investigator then plots the mutant frequency (number of viable mutants/cell culture dish)/ (plating efficiency of cells Â number of cells seeded per dish) on the ordinate (y-axis) versus the concentration of the mutagen on the abscissa (x-axis). For a strong mutagen, there is usually a dose-response effect, that is, the mutant frequency increases, usually linearly, as a function of increasing concentration of mutagen added to cells.
The mutant colonies are resistant to the cytotoxicity of 6-thioguanine, because they have been mutated at the gene encoding the enzyme, hypoxanthine-guanine phosphoribosyltransferase (HGPRT), such that the activity of this enzyme is decreased or abolished. This enzyme carries out a reaction between the DNA bases hypoxanthine or guanine and PRPP to form inosine and guanosine, which are then incorporated into DNA and RNA. In mutant cells, the gene encoding the HGPRT enzyme, hence the enzyme, itself, is mutated. Therefore, the enzyme has a substantially reduced ability, or no ability, to carry out this condensation. The mutant cells consequently cannot react toxic 6-thioguanine with PRPP to form a toxic nucleotide and are therefore resistant to the cytotoxicity of 6-thioguanine/ 8-azaguanine. They therefore survive and form colonies even in the presence of 6-thioguanine or 8-azaguanine. Plotting the mutation frequency versus the concentration of mutagen added yields linear curves. This is a general assay and, as a forward mutation assay, it detects base substitution, addition, deletion, and frameshift mutations. It is one of the most widely used mutation assays in mammalian cells.
A similar assay is one in which L5178Y mouse lymphoma cells containing one active and one inactive gene encoding thymidine kinase are selected in trifluorothymidine. This treatment is lethal to wild-type cells. However, spontaneous mutants, and those induced by mutagens, have mutations in the second copy of the thymidine kinase gene, hence do not phosphorylate trifluorothymidine, and are resistant to the toxicity of this drug. This mutation assay is very valuable, because it detects point mutations, and it also detects mutations involving large amounts of damage to the chromosome, measured as resistant colonies with a small size.
A third assay that has been used to detect mutations in mammalian cells induced by chemical carcinogens and UV and ionizing radiations is that of mutation to ouabain resistance. Ouabain is a cardiac glycoside that binds specifically to the large subunit of the enzyme, sodium, potassium adenosine triphosphatase [(Na,K) ATPase]. The (Na,K) ATPase is an enzyme located in the plasma membrane of mammalian cells. This enzyme hydrolyzes ATP and uses the resultant energy liberated to drive electrogenic transport of sodium ion out of the cell and transport of potassium ion into the cell. The transport is not equal, and three sodium ions are transported out of the cell, while two potassium ions are transported into the cell. The resultant electrogenic gradient is used to drive the transport of glucose and certain types of amino acids into the cell and to regulate cell volume, which are all crucial for cell survival. When cells are treated with the cardiac glycoside -ouabain, ouabain binds to a specific binding site on the large subunit of the (Na,K) ATPase and inhibits the activity of this enzyme. As a result of this binding, the enzymatic activity of the (Na,K) ATPase is inhibited, and the transport of glucose and certain amino acids and the regulation of cell volume, which are dependent on the activity of the (Na,K) ATPase, are inhibited, and cells die. Hence, ouabain at a concentration of 3 mm will kill murine fibroblasts down to spontaneous mutant frequencies (one mutant/one million wild-type cells). Treating murine fibroblasts, such as C3H/ 10T1/2 Cl 8 mouse embryo cells, with mutagens such as MNNG or BaP, induces mutations in the gene encoding the large subunit of the (Na,K) ATPase, such that the ouabain binding site is mutated. Hence, ouabain will no longer bind to the large subunit of the (Na,K) ATPase, and these mutant cells are resistant to the cytotoxicity of ouabain and will form mutant colonies in the presence of ouabain. This assay detects a restricted set of base substitution mutations which will mutate the ouabain binding site but not affect the other enzymatic properties of the (Na,K) ATPase. It is thought that frameshift mutagens produce ouabain-resistant mutants but that these frameshifted mutants have a sufficiently damaged (Na,K) ATPase that these mutants are not viable.
Chromosome Breakage and Micronucleus Formation
In mammalian cells, the genes are arranged on discrete chromosomes. There are many assays that have been developed in mammalian cells to measure the ability of specific chemicals and ionizing and UV radiations to induce damage to these chromosomes, referred to as chromosomal aberrations. In these assays, the cells are seeded, treated with the chemical or radiation of interest, then treated with colcemid to arrest the cells in metaphase. The cells are then swelled in hypotonic potassium chloride. The swelled cells are then dropped onto microscope slides, which bursts the cells and produces what is called a metaphase spread or display of chromosomes. The chromosomes in these metaphase spreads are then stained with the nuclear stain, Giemsa stain, and examined by microscope to quantitate the numbers of chromosome aberrations present in the treated cells. Typical chromosomal aberrations that are scored include gaps, breaks, dicentrics (where parts of two chromosomes fuse, such that the resultant structure bears two centromeres), satellite associations, and ring chromosomes. Most mutagenic chemical carcinogens and ionizing and UV radiations have the ability to induce chromosome aberrations in mammalian cells. Translocations, in which one chromosome is broken and one or more parts of it are fused to another chromosome, can also be recognized with this assay. At sufficiently low concentrations, where cytotoxicity exerted by a chemical is sufficiently low, the induction of chromosome aberrations by chemical mutagens is linear as a function of the concentration of the chemical mutagen tested. Chemicals and radiations that can induce chromosome aberrations are referred to as clastogens.
A second type of damage that can be induced by chemical mutagens and ionizing and UV radiation is called micronucleus formation. In this assay, cells are treated with the chemical or radiation of interest, and then the cells are treated with cytochalasin B to inhibit cytokinesis. The cells are then visualized by staining with acridine orange. Micronuclei can be visualized under the microscope. Micronuclei are vesicles containing one or more whole chromosomes or pieces of chromosomes. The implication of observing micronuclei is that on further rounds of cell division, these micronuclei containing chromosomes or pieces of chromosomes, and hence the genetic information that they contain, can be lost from cells. Hence, formation of micronuclei indicates that large amounts of genetic material can be lost from cells, as much as that contained on an entire chromosome.
In Vivo Genetic Toxicology Assays
Assays to detect gene mutations and chromosome aberrations can also be conducted in yeasts, fungi, plants, and insects. In the fruit fly, Drosophila, chemical mutagenesis has been studied since l941. The sex-linked recessive lethal test in Drosophila measures the presence of recessive lethal mutations in 600-800 different loci on the X chromosome. In this assay, the presence or absence of wild-type males in the offspring of specifically designed genetic crosses is screened for. Genetic and cytogenetic assays in plants are also used to detect mutations and chromosomal aberrations in plants. In mammals, mutations can be detected by treating intact animals and assaying various tissues to determine whether mutations or cytogenetic effects have occurred. The mouse spot test is a very widely used assay to detect in vivo genetic damage. In this assay, the investigator detects visible spots of altered pigment in mice that are heterozygous for genes encoding coat color, which indicates that there are mutations in the precursor cells of the altered regions. Cells can also be collected from animals (or humans) that have been exposed to mutagens or carcinogens and analyzed to determine whether they have mutations. For instance, an important assay is the harvesting of human peripheral blood lymphocytes from animals or humans exposed to chemical mutagens, the selection of cells mutated in the hypoxanthine-guanine phosphoribosyl transferase (HGPRT) gene, and the sequencing of this gene to determine which exact mutations have occurred. Cells can also be harvested from animals or humans exposed to chemical mutagens or radiations, and these cells can be assayed for micronucleus formation, for chromosome aberrations, or for chromosomal aneuploidy. These assays are particularly useful in demonstrating that when humans are exposed to genotoxic chemicals, actual genotoxic damage in the form of mutations, micronuclei, or chromosome aberrations occurs in the human.
Induction of Morphological and Neoplastic Transformation in Mammalian Cells: Cell Culture Models for Chemically Induced Cancer Proceeding through Mutagenesis
There is a group of mammalian cell-based assays that can be utilized to study the ability of chemical carcinogens, UV or ionizing radiations, or minerals such as asbestos to convert normal cells into morphologically transformed cells (cells whose morphology or shape is transformed or changed), when normal cells are grown in cell culture and treated with these carcinogens. One property of normal cells, particularly fibroblasts (connective tissue cells), is that they divide, grow, and eventually fill a surface such as that of a tissue culture dish, and then stop growing when they contact each other. This is because fibroblastic cells in contact transmit signals through their membranes, to the cytoskeleton (cell skeleton, consisting of microtubules and microfilaments), and on to the cell nucleus. When these signals reach the cell nucleus, this triggers induction of a negative feedback signal, which forces cells to stop growing. This property is referred to as 'contact inhibition of cell division.' In cell culture, this property is manifested when the cells grow and fill the cell culture dish with a layer of cells one cell thick. The number of cells that are present in the dish when the cells have filled the dish is termed the 'saturation density. ' However, when fibroblastic cells are treated with a chemical carcinogen that is already activated to an electrophile (electronloving chemical species that can bind to DNA bases covalently) or that can be activated by the specific types of cytochrome P450 enzymes the cell possesses to an electrophile, then this electrophilic species binds covalently to the DNA bases of the cells, forming 'DNA-carcinogen covalent adducts.' There is a high probability that these carcinogen-DNA covalent adducts will be repaired incorrectly, leading to mutations in the cell. When these mutations occur in proto-oncogenes, activating them to oncogenes, and in tumor suppressor genes, inactivating them, and approximately 15 such mutations occur, this will degrade control of global gene expression, such that the cell becomes degraded, loses contact inhibition of cell division, and becomes morphologically transformed. For a mutagenic carcinogen, there is a dosedependent induction of morphological transformation, and then, 1% or less of the cells are 'morphologically transformed' or their cell shape is transformed or changed. They have lost contact inhibition and now grow on top of one another in arrays, where the cells 'crisscross' over one another. Since the fibroblastic cells are changed in shape or morphology, it was referred to as 'morphological transformation' or change in cell shape. This change in cell shape manifests itself as an overgrowth of the cells above the monolayer, in small piles, referred to as 'foci' of morphologically transformed cells. Foci are easily seen when cells are stained with specific dyes, such as Giemsa stain, which stains the nuclei of cells. The stained foci can then be scored and counted under a dissecting microscope. Scoring foci is an assay for detecting chemical carcinogens, because this detects one of the five steps that must be accomplished for fibroblastic cells to become able to form tumors when injected into immunosuppressed mice. These five steps are induction of (1) aneuploidy, (2) cellular immortality, (3) morphological transformation, (4) anchorage-independent cell transformation, and (5) neoplastic cell transformation or tumorigenicity.
A second property of most normal cells is that they need to anchor to a surface, such as that of a tissue culture dish, in order for them to replicate their DNA and divide. This property is referred to as 'anchorage dependence.' Most normal cells cannot grow in suspension in liquid medium. An exception to this is white blood cells, which can grow in liquid suspension because this is their normal environment when they are circulating in the blood of mammals. However, most normal types of cells, particularly connective tissue cells like fibroblasts and also epithelial cells, cannot grow in liquid suspension and are referred to as 'anchorage dependent' for cell growth. When fibroblasts are treated with chemical carcinogens that are already activated to alkylating agents or if the cells themselves have the cytochrome P450 enzymes to activate the carcinogens they are treated with, then a small fraction, on the order of 1 in 1 million, of the normal cells will be converted into anchorageindependent cells in a manner that is dose dependent upon the amount of carcinogen added to the cells. Anchorage-independent cells can grow and form colonies in liquid suspension, in a semisolid medium such as 0.3% agar or agarose, which has the approximate consistency of jello. Anchorage independence is another property that must be acquired by fibroblasts, and often by epithelial cells, before they can become tumorigenic.
Normal cells also have a finite life span and undergo w60 population doublings, then senesce or die through a process of programmed cell death. When cells are treated with chemical carcinogens or UV or ionizing radiations, a small fraction of them (1/1000 in mouse cells and on the order of 1/1 million in human cells) can become transformed to immortality, such that they now grow forever in cell culture, as also presumably in the organism from which they were derived. Acquisition of cellular immortality is a third step on the road to tumorigenicity and can be acquired when cells are treated with chemical carcinogens or UV or ionizing radiations. Cellular immortality is relatively easy to induce in cultured murine cells, but much more (approximately 100 000-fold more) difficult to induce in cultured human cells, likely due to the greater stability of the chromosomal complement of human cells compared to that of murine cells.
A final step on the route to development of tumor cells involves conversion of fibroblastic cells that have become immortal, morphologically transformed, and anchorage independent, into tumor cells. This can occur spontaneously or upon treatment of cells with chemical carcinogens or UV or ionizing radiations.
What changes in the DNA result in the induction of the changes in cell properties (phenotypes) that were referred to as morphological transformation, anchorage independence, cellular immortality, and tumorigenicity? There are two broad classes of genes that control cell growth in a positive way: the protooncogenes, which control cell growth and signal transduction, and the tumor suppressor genes, which inhibit cell growth. Mutagenic chemical carcinogens either already are electrophiles or can be converted to electrophiles by cytochrome P450 enzymes. These electrophilic metabolites of mutagenic carcinogens can then covalently bind to DNA bases to form DNA base-carcinogen adducts. Misrepair of these DNA basecarcinogen adducts, when they occur in proto-oncogenes, can cause mutations in, amplification of, or translocation of protooncogenes, converting them into active cell-transforming genes known as activated oncogenes. There are w50 proto-oncogenes that can be converted into activated oncogenes.
There are four broad classes of proto-oncogenes. One class of proto-oncogenes encodes protein products localized in the cell nucleus which act as factors that activate transcription of specific genes. This group is exemplified by genes such as c-myc and c-jun. A second group is located in the cell membrane or the cytoplasm and transfers biochemical signals in the cell. A prominent example of this group is the c-Ha-ras proto-oncogene. The protein product of this gene binds the high-energy molecule guanosine triphosphate, which activates this protein such that it transfers signals to other proteins and eventually toward the nucleus. The protein products of the last two groups of protooncogenes are located at the membrane and are growth factors and receptors for these growth factors. The c-sis gene is an example of this type of proto-oncogene. The significance of these genes is that mutational or other types of activations of two or more of these genes play a role in inducing transformed phenotypes and contribute to formation of a tumor cell.
There are w50 tumor suppressor genes that have been identified to date. Chemical carcinogens cause mutations in these genes to inactivate them or can break the chromosomes on which these genes are located or can cause loss of an entire chromosome bearing a tumor suppressor gene from the cell. Some chemical carcinogens, such as insoluble carcinogenic nickel compounds, including green nickel oxide, black nickel oxide, crystalline nickel sulfide, and nickel subsulfide, can inactivate tumor suppressor genes by causing a condensation of chromatin around actively transcribed tumor suppressor genes, leading to methylation and transcriptional inactivation of these tumor suppressor genes. Inactivation of the two copies of a tumor suppressor gene by these mechanisms renders them functionally inactive in the cell. Inactivation by chemical carcinogens of two or more tumor suppressor genes, in concert with activation of two or more protooncogenes into oncogenes, cumulatively degrades the control of global gene expression in the cell, leading to formation of a tumor cell. Examples of tumor suppressor genes include the retinoblastoma (Rb) gene and the p53 tumor suppressor gene. Inactivations of tumor suppressor genes and activations of specific oncogenes have been found in all human and mouse tumors that have been studied intensively to date.
Tier Concept of Screening and Detecting Chemical Mutagens and Mutagenic Chemical Carcinogens
Genetic toxicology, the science by which chemicals and agents that cause mutation and other changes to DNA are studied, has evolved substantially during the past 60 years. It is now a standard practice to detect chemical mutagens by utilizing the Ames' bacterial mutagenesis assay and other bacterial mutagenesis assays, both with and without S-9 metabolic activation, and to utilize assays detecting mutation to 6-thioguanine resistance in CHO or V79 mammalian cells. There are also assays that detect the ability of chemicals to cause chromosome breakage and micronucleus formation in Chinese hamster V79 cells or CHO cells by treating these cells with specific chemicals or UV or ionizing radiation, then treating the cells with colcemid to arrest the cells in S phase, treating the cells with hypotonic saline solution to swell them, and dropping the cells from a pipette onto microscope slides to prepare metaphase spreads of the chemically or radiation-treated cells. One can then examine the chromosomes of these cells under a microscope and determine whether there are chromosome aberrations in the forms of gaps, breaks, fragments, dicentrics, and satellite associations.
Assays that detect the ability of chemical carcinogens or UV or ionizing radiations to induce unscheduled DNA synthesis, or DNA repair, are also commonly used in the tier concept to identify DNA interaction as an indication for genotoxic carcinogenicity. However, it should be pointed out that DNA damage often but not always leads to mutation or carcinogenicity. Much of this DNA damage is repaired correctly. Further, carcinogenicity is a multistep process, and some steps may not be mutations. In addition, some carcinogens cause phenotypic alterations by inducing epigenetic effects, affecting the silencing of tumor suppressor genes by methylating their promoters, or causing expression of proto-oncogenes by removing methyl groups from their promoters, not by causing mutations. In one of these DNA repair assays, the cells are treated with chemicals or radiations, then with tritiated thymidine, and autoradiography is used to measure the incorporation of tritiated thymidine into the DNA of cells treated with these agents while the cells are in G1 or G0 phases of the cell cycle. This guarantees that no normal DNA synthesis is occurring, so that any DNA synthesis that does occur is due to the repair of damaged DNA, called 'unscheduled DNA synthesis.' The autoradiographic procedure then allows the investigator to determine whether the cells have taken up tritiated thymidine and incorporated tritiated thymidine into DNA.
All the assays mentioned above are commonly used simultaneously to detect the genotoxic properties of chemicals or radiation in what is referred to as a 'battery' of tests. This battery of tests usually constitutes what is termed a primary screen for mutagens and is used to determine whether a specific chemical is a mutagen.
These methodologies can be used to detecting chemical mutagens. In addition, these methodologies can also be used to detect mutagenic chemical carcinogens by detecting the mutagenicity of these carcinogens, since approximately 50% of all carcinogens are mutagenic carcinogens and can be detected as mutagens in the Ames' Salmonella mutagenicity assay. The most certain way to detect chemical carcinogens, of course, is to administer the chemical carcinogens to lower animals. This can be done (1) by painting the skin of animals with solutions or suspensions of carcinogens, (2) by feeding carcinogens to animals or adding the carcinogens to the animals' stomachs by a gavage procedure, or (3) by adding carcinogens to the animals' drinking water and then observing whether the animals develop tumors. Usually, the chemical carcinogens are administered to the animals by the chosen route of administration many times in order to induce formation of benign and malignant tumors. Unfortunately, treating mice or rats with chemical carcinogens and assaying for tumor induction takes 2 years and costs approximately US $10 million per chemical tested. These whole animal carcinogenicity assays are still widely used to determine whether specific chemicals are carcinogens.
However, the cost of carcinogenicity testing is simply too large and the time it takes too long to permit scientists to use animal bioassays to screen widely, rapidly, and routinely for the carcinogenicity of the hundreds of thousands of chemicals that need to be studied. During the past 20 years, an alternate strategy to detect carcinogens has therefore arisen. This strategy is referred to as a tier screening strategy and relies on the fact that w50% of the known chemical carcinogens are also mutagens and therefore cause carcinogenicity in part by causing mutations in proto-oncogenes, activating them to oncogenes, and by causing mutations in tumor suppressor genes, inactivating them. Hence, the current strategy relied on by most government, regulatory, and academic laboratories is to use inexpensive, rapid, in vitro assays to test the large number of chemicals in use today in what is referred to as a primary screen using a battery of genetic toxicology assays, as outlined above. In this primary screen, one would use the Ames' bacterial mutagenesis assay, an assay for chromosome breakage, occasionally an assay to detect micronucleus formation, an assay to detect induction of DNA repair, and a mammalian cell mutagenesis assay. Chemicals that cause mutagenesis, chromosome breakage, or DNA repair in these assays would be considered suspect carcinogens. The more of these primary screening tests that the suspect chemical is positive in, the greater the confidence of the investigator that the chemical is a mutagen, and hence a likely carcinogen. If the chemical causes positive results in a number of these primary screening assays, then further product development on these chemicals would likely be halted or the chemicals would be modified in their structure by chemical synthesis, to attempt to abrogate the mutagenicity of the original chemical. Chemicals negative in this primary screen that were proposed to be used for human applications, such as food additives or cosmetics, would then be tested in cell transformation assays for the ability to induce morphological or anchorage-independent transformation, in what is considered a secondary screen. Chemicals positive in cell transformation assays are then eliminated from further development or chemically modified so they no longer cause cell transformation. Finally, chemicals to be marketed as cosmetics or food additives would then be tested in whole animal carcinogenesis assays. Only those that were not carcinogenic would ideally then be marketed to the public or used in commerce where large numbers of people would be exposed to them.
